UNIVERSIDAD DE OVIEDO

Their core work

Universidad de Oviedo is a Spanish public university with deep strengths in molecular biology, microbiology, and materials science, particularly in antibiotic resistance, biofilm control, and biocatalysis. They run significant research in ageing mechanisms, nano-optics of 2D materials, and environmental management of European river systems. Their work bridges fundamental science — from antibiotic-producing streptomycetes to artificial fluorescent proteins — with applied outcomes in health, energy, and environmental policy.

What they specialise in

How they've shifted over time

In 2014–2018, UNIOVI's H2020 portfolio was broad and exploratory: environmental management (river barriers, invasive species), mineral processing (tungsten/tantalum), gender equality research, and science communication events. From 2019 onward, a clear molecular biology and biotechnology focus emerged — synthetic biology, antimicrobial resistance, biofilm engineering, and biocatalytic cascades became dominant themes. Their coordinated projects increasingly concentrated on microbiology and health-adjacent research, suggesting a deliberate institutional push toward life sciences applications.

UNIOVI is consolidating around microbial biotechnology, antimicrobial surfaces, and enzyme engineering — expect them to pursue projects in sustainable biomanufacturing and anti-infective materials.

How they like to work

UNIOVI splits roughly 60/40 between participant and coordinator roles, showing they can both lead and contribute within consortia. With 280 unique partners across 33 countries, they maintain a wide European network rather than relying on a small circle of repeat collaborators. Their coordinated projects tend to be smaller and more focused (MSCA fellowships, targeted RIAs), while they join larger consortia as a specialist contributor — a pattern that suggests they are reliable partners who scale their commitment to the project scope.

Extensive European network spanning 280 partners across 33 countries, indicating broad reach well beyond Iberian collaborations. Their participation in pan-European networks like SOLARNET, ORCHESTRA, and EuropaBON shows they integrate easily into large multi-country consortia.

What sets them apart

UNIOVI combines deep microbiology expertise (antibiotic resistance, biofilms, streptomycetes) with strong biocatalysis and materials science capabilities — a combination that is relatively rare among Spanish universities in H2020. Their coordinated ERC-level project on ageing (DeAge, EUR 2.4M) signals research leadership at the highest level. For consortium builders, they offer the advantage of a mid-sized university that can coordinate focused research while also contributing specialist knowledge in microbial biotechnology to larger programmes.

Highlights from their portfolio

• DeAge
  Largest single project (EUR 2.4M) as coordinator — an ERC-scale investigation into molecular mechanisms of ageing, progeria, and proteostasis.
• 2DNANOPTICA
  EUR 1.5M coordinated project bridging graphene research with nano-bio-photonics, showing capacity to lead interdisciplinary materials science.
• BREAK BIOFILMS
  Coordinated project combining microbiology, nanomaterials, and surface engineering to design next-generation anti-biofilm interfaces — directly applicable to medical devices.